Drägerwerk AG & Co. KGaA (ETR:DRW8)
55.60
+0.80 (1.46%)
Aug 8, 2025, 1:39 PM CET
Drägerwerk AG & Co. KGaA Revenue
Drägerwerk AG & Co. KGaA had revenue of 779.99M EUR in the quarter ending June 30, 2025, a decrease of -0.60%. This brings the company's revenue in the last twelve months to 3.36B, down -0.03% year-over-year. In the year 2024, Drägerwerk AG & Co. KGaA had annual revenue of 3.37B, down -0.08%.
Revenue (ttm)
3.36B
Revenue Growth
-0.03%
P/S Ratio
0.34
Revenue / Employee
202.34K
Employees
16,585
Market Cap
1.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.37B | -2.62M | -0.08% |
Dec 31, 2023 | 3.37B | 328.28M | 10.78% |
Dec 31, 2022 | 3.05B | -283.19M | -8.51% |
Dec 31, 2021 | 3.33B | -77.86M | -2.29% |
Dec 31, 2020 | 3.41B | 625.45M | 22.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Drägerwerk AG & Co. KGaA News
- 9 days ago - Drägerwerk AG & Co. KGaA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 9 days ago - Drägerwerk AG & Co. KGaA (DGWPF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Draegerwerk: Record Demand Surge in Early 2025 Orders! - Wallstreet:Online
- 10 days ago - EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years - Wallstreet:Online
- 27 days ago - Drägerwerk: H1 2025 Earnings Dip, Orders Surge, Forecast Steady - Wallstreet:Online
- 27 days ago - EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – significant increase in order intake – forecast confirmed - Wallstreet:Online
- 4 weeks ago - EQS-AFR: Drägerwerk AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 2 months ago - EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission - Wallstreet:Online